ORDINARY SHARE PURCHASE WARRANT POLYPID LTD.PolyPid Ltd. • August 2nd, 2024 • Surgical & medical instruments & apparatus • New York
Company FiledAugust 2nd, 2024 Industry JurisdictionTHIS ORDINARY SHARES PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [__________] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Issuance Date (the “Initial Exercise Date”) and on or prior to the earlier of (i) 5:00 p.m. (New York City time) on August 6, 2026 and (ii) the 10th Trading Day following the date on which the Company issues a press release announcing the recommendation by Data Safety Monitoring Board regarding its unblinded interim analysis in the Company’s SHIELD II Phase 3 trial resulting in (a) the stopping of the trial due to positive efficacy; or (b) continuation to planned final (up to 630 subjects) (the “Termination Date”) but not thereafter, to subscribe for and purchase from PolyPid Ltd., an Israeli company (the “Company”), up to [______] ordinary shares, no par value per share (the “Ordinary Share(s)”) (as subject to adjus
PRE-FUNDED ORDINARY SHARE PURCHASE WARRANT POLYPID LTD.PolyPid Ltd. • August 2nd, 2024 • Surgical & medical instruments & apparatus • New York
Company FiledAugust 2nd, 2024 Industry JurisdictionTHIS PRE-FUNDED ORDINARY SHARES PURCHASE WARRANT (the “Warrant”) certifies that, for value received, [__________] or its assigns (the “Holder”) is entitled, upon the terms and subject to the limitations on exercise and the conditions hereinafter set forth, at any time on or after the Issuance Date (the “Initial Exercise Date”) and until this Warrant is exercised in full (the “Termination Date”) but not thereafter, to subscribe for and purchase from PolyPid Ltd., an Israeli company (the “Company”), up to [______] ordinary shares, no par value per share (the “Ordinary Share(s)”) (as subject to adjustment hereunder, the “Warrant Shares”). The purchase price of one Ordinary Share under this Warrant shall be equal to the Exercise Price, as defined in Section 2(b). This Warrant was issued pursuant to that certain Securities Purchase Agreement, dated as of August 1, 2024, by and between the Company, the Holder and other purchasers signatory thereto (as may be amended, amended and restated, su